NEXI

NexImmune, Inc. NEXI

NEXI
NexImmune, Inc. CDIO
Cardio Diagnostics Holdings, Inc. SONN
Sonnet BioTherapeutics Holdings, Inc. ZVSA
ZyVersa Therapeutics, Inc. XFOR
X4 Pharmaceuticals, Inc. TLIS
Talis Biomedical Corporation FNCH
Finch Therapeutics Group, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode NEXI CDIO SONN ZVSA XFOR TLIS FNCH
6M 0.00 % -65.84 % 241.86 % -79.22 % -50.95 % -14.29 % -1.61 %
YTD -99.92 % -84.17 % 175.63 % -85.32 % -86.30 % -11.76 % 7.96 %
1Y -99.96 % -34.34 % -4.75 % -93.10 % -81.54 % -11.20 % 4.72 %
3Y -100.00 % -98.62 % -98.03 % -100.00 % -94.80 % -86.81 % -75.05 %
5Y -100.00 % -98.59 % -99.97 % -100.00 % -98.57 % -99.64 % -98.09 %
10Y -100.00 % -98.59 % -100.00 % -100.00 % -99.88 % -99.64 % -98.09 %
From the beginning -100.00 % -98.59 % -100.00 % -100.00 % -99.88 % -99.64 % -98.09 %

Dividend